JAK1 |
IFNα/β, IFNγ, IL-2, IL-4, IL-7, IL-9, IL-21, IL-6 family cytokines, IL-10 family cytokines |
Perinatally lethal |
GOF somatic mutations cause ALL, AML, solid organ malignancies |
JAK2 |
IFNγ, IL-3, IL-5, GM-CSF, EPO, TPO, G-CSF, GH, leptin |
Embryonically lethal due to absence of erythropoiesis |
GOF mutations cause PCV, MF, ET, hypercoagulable STATe; somatic mutations associated with acute and chronic hematologic malignancies |
JAK3 |
IL-2, IL-4, IL-7, IL-15, IL-21 |
Defective T and B cell maturation |
Loss of function mutation causes severe combined immunodeficiency (SCID), Jacobsen syndrome |
TYK2 |
IFNα/β, IFNγ, IL-12, IL-23 |
Reduced responses to Type I IFN and IL12, and defective Stat3 activation. |
Loss-of function mutation causes primary immunodeficiency |
STAT1 |
All IFNs |
Impaired responses to Type I and Type II IFN |
LOF mutations confer susceptibility to mycobacterial and viral infections; GOF mutations cause chronic mucocutaneous candidiasis |
STAT2 |
Type I IFNs |
Impaired response to Type I IFN and susceptibility to viral infections |
Deficiency causes increased susceptibility to viral mutations |
STAT3 |
Il-6 and other gp130 cytokines |
Embryonically lethal |
LOF mutations cause AD-HIES; GOF somatic mutations strongly associated with LGL |
STAT4 |
IL-12, IL-23, type I interferons |
Mutations in mouse inhibit Th1 differentiation |
Polymorphisms associated with RA, SLE |
STAT5a/STAT5b |
IL-2, EPO, TPO, GM-CSF, GH, IL-7 |
Defective hematopoietic cell lines |
Deficiency causes autoimmunity, bleeding diathesis, immunodeficiency and dwarfism; somatic mutations associated with LGL |
STAT6 |
IL-4, IL-13 |
Mutations in mouse inhibit T helper 2 differentiation |
Polymorphisms associated with asthma, atopy, increased levels of IgE |